tiprankstipranks
Trending News
More News >
Chimeric Therapeutics Ltd. (AU:CHM)
ASX:CHM
Australian Market
Advertisement

Chimeric Therapeutics Ltd. (CHM) Income Statement

Compare
12 Followers

Chimeric Therapeutics Ltd. Income Statement

Last quarter (Q4 2025), Chimeric Therapeutics Ltd.'s total revenue was AU$3.57M, an increase of 405.12% from the same quarter last year. In Q4, Chimeric Therapeutics Ltd.'s net income was AU$-3.79M. See Chimeric Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 3.97MAU$ 7.46MAU$ 0.00AU$ 2.62MAU$ 2.65K
Gross Profit
AU$ 3.12MAU$ 7.45MAU$ 3.54MAU$ 1.67MAU$ -844.31K
Operating Expenses
AU$ 18.23MAU$ 19.77MAU$ 29.49MAU$ 13.62MAU$ 14.00M
Depreciation and Amortization
AU$ 1.03MAU$ 1.01MAU$ 965.35KAU$ 949.76KAU$ 846.96K
EBITDA
AU$ -9.08MAU$ -11.30MAU$ -28.59MAU$ -13.62MAU$ -14.26M
Operating Income
AU$ -15.11MAU$ -12.31MAU$ -29.49MAU$ -14.57MAU$ -14.85M
Other Income/Expenses
AU$ 4.79MAU$ -3.97MAU$ -842.60KAU$ -1.16MAU$ -267.02K
Pretax Income
AU$ -10.32MAU$ -16.28MAU$ -30.33MAU$ -15.73MAU$ -15.11M
Net Income
AU$ -10.43MAU$ -12.53MAU$ -25.92MAU$ -15.90MAU$ -15.11M
Per Share Metrics
Basic EPS
AU$ -0.01AU$ -0.02AU$ -0.06AU$ -0.04AU$ -0.05
Diluted EPS
AU$ -0.01AU$ -0.02AU$ -0.06AU$ -0.04AU$ -0.05
Weighted Average Shares Outstanding
1.35B 695.68M 433.24M 359.93M 325.51M
Weighted Average Shares Outstanding (Diluted)
1.35B 695.64M 433.24M 359.93M 325.50M
Currency in AUD

Chimeric Therapeutics Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis